Elixinol Wellness Limited (OTCMKTS:ELLXF – Get Free Report) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totaling 1,413 shares, a growth of 2,971.7% from the December 15th total of 46 shares. Based on an average daily trading volume, of 32,681 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 32,681 shares, the short-interest ratio is currently 0.0 days.
Elixinol Wellness Stock Performance
Shares of OTCMKTS:ELLXF remained flat at $0.01 during midday trading on Monday. 75 shares of the stock traded hands, compared to its average volume of 13,671. The stock has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.01. Elixinol Wellness has a one year low of $0.00 and a one year high of $0.04.
About Elixinol Wellness
Elixinol Wellness Inc is a wellness company specializing in the development, manufacture and distribution of hemp-derived cannabidiol (CBD) products and nutraceuticals. The company’s product portfolio encompasses oral formulations such as tinctures, softgels and capsules; topicals including creams, balms and salves; and consumables such as gummies and nutraceutical beverages. By integrating hemp extraction technologies with standardized dosing, Elixinol Wellness seeks to deliver consistent consumer experiences across its core brand and select private-label partnerships.
Elixinol Wellness distributes its products through a combination of direct-to-consumer e-commerce platforms, national and regional retail chains, specialty health stores and international wholesale channels.
Further Reading
- Five stocks we like better than Elixinol Wellness
- Which stock will the White House buy next?
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Elixinol Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elixinol Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
